Stay updated with breaking news from லாரி அவசரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stony Brook's First Hand Surgeon Performs His Last Operation | stonybrook.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stonybrook.edu Daily Mail and Mail on Sunday newspapers.
Ex-KCSO mechanic admits to official misconduct charge, seeks diversion wbir.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wbir.com Daily Mail and Mail on Sunday newspapers.
Pioneros de PRA Health Sciences conectan pacientes de ensayos clínicos con sus datos del mundo real con Synoma tynmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tynmagazine.com Daily Mail and Mail on Sunday newspapers.
PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act. RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma ®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios. ....
13 may 2021 PRA Health Sciences pioneers connecting clinical trial patients with their real-world data with Synoma Pharmaceutical, biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act. RALEIGH, N.C., May 13, 2021 (GLOBE NEWSWIRE) PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today an innovative tokenization solution using Synoma ®, PRA’s proprietary technology that allows for the generation of enhanced evidence for drug development. PRA’s solution makes it possible to connect clinical trial data and secondary data sets with privacy at the forefront. Today, three large pharmaceutical companies, along with several other pharmaceutical and biotech companies of all sizes, are using Synoma to link data and conduct analyses across their drug development portfolios. ....